Human serum paraoxonase (PON1) concentration predicts cardiovascular disease in diabetic patients

被引：0
|
作者：
Inoue, M. [1 ]
Ikeda, Y. [1 ]
Suehiro, T. [1 ]
Takata, H. [1 ]
Inada, S. [1 ]
Ogami, N. [1 ]
Osaki, F. [1 ]
Arii, K. [1 ]
Hashimoto, K. [1 ]
机构：
[1] Kochi Univ, Sch Med, Nankoku, Kochi, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81393-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
WeP1137
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [31] The human serum paraoxonase arylesterase gene (PON1) is one member of a multigene family
    PrimoParmo, SL
    Sorenson, RC
    Teiber, J
    LaDu, BN
    GENOMICS, 1996, 33 (03) : 498 - 507
  • [32] Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease
    Samouilidou, Elisabeth
    Kostopoulos, Vassilis
    Liaouri, Augustina
    Kioussi, Eva
    Vassiliou, Kyriaki
    Bountou, Eirini
    Grapsa, Eirini
    RENAL FAILURE, 2016, 38 (10) : 1601 - 1606
  • [33] A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression
    Suehiro, T
    Nakamura, T
    Inoue, M
    Shiinoki, T
    Ikeda, Y
    Kumon, Y
    Shindo, M
    Tanaka, H
    Hashimoto, K
    ATHEROSCLEROSIS, 2000, 150 (02) : 295 - 298
  • [34] Novel Nucleophiles Enhance the Human Serum Paraoxonase 1 (PON1)-mediated Detoxication of Organophosphates
    Chambers, Janice E.
    Chambers, Howard W.
    Meek, Edward C.
    Funck, Kristen E.
    Bhavaraju, Manikanthan H.
    Gwaltney, Steven R.
    Pringle, Ronald B.
    TOXICOLOGICAL SCIENCES, 2015, 143 (01) : 46 - 53
  • [35] Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease
    Milaciu, Mircea Vasile
    Vesa, Stefan Cristian
    Bocsan, Ioana Corina
    Ciumarnean, Lorena
    Sampelean, Dorel
    Negrean, Vasile
    Pop, Raluca Maria
    Matei, Daniela Maria
    Pasca, Sergiu
    Rachisan, Andreea Liana
    Buzoianu, Anca Dana
    Acalovschi, Monica
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [36] Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake
    Ponce-Ruiz, Nestor
    Murillo-Gonzalez, Fatima E.
    Rojas-Garcia, Aurora E.
    Bernal Hernandez, Yael Y.
    Mackness, Mike
    Ponce-Gallegos, Jaime
    Barron-Vivanco, Briscia S.
    Hernandez-Ochoa, Isabel
    Gonzalez-Arias, Cyndia A.
    Ortega Cervantes, Laura
    Cardoso-Saldana, Guillermo
    Medina-Diaz, Irma M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (01) : 40 - 48
  • [37] Alterations in paraoxonase (PON1) activity in patients with chronic kidney disease (CKD)
    Liberopoulos, Evangelos
    Papavasiliou, Eleni
    Miltiadous, George
    Katopodis, Kostantinos
    Pappas, Michael
    Tselepis, Alexandros
    Elisaf, Moses
    SIamopoulos, Kostas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 432 - 432
  • [38] A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM
    Kao, YL
    Donaghue, K
    Chan, A
    Knight, J
    Silink, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07): : 2589 - 2592
  • [39] Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
    Unsal, Cuneyt
    Albayrak, Yakup
    Albayrak, Neslihan
    Kuloglu, Murat
    Hashimoto, Kenji
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1545 - 1552
  • [40] Paraoxonase1 192 (PON1 192) Gene Polymorphism and Serum Paraoxonase Activity in Panic Disorder Patients
    Atasoy, Hande
    Gulec-Yilmaz, Seda
    Ergen, Arzu
    Gormus, Uzay
    Kucukhuseyin, Ozlem
    Dalan, Burak
    Ol, Kevser Kusat
    Ogut, Dicle Bilge
    Gulec, Huseyin
    Cetin, Bugra
    Timirci-Kahraman, Ozlem
    Ormeci, Burcu
    Ucunoglu, Nazli
    Gultekin, Guldal Inal
    Isbir, Turgay
    IN VIVO, 2015, 29 (01): : 51 - 54
12345